Colleen Gaffney
Family · Chestnut Hill, MANPI 1649780438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$706
- Johnson & Johnson$544
- Novartis$328
- UCB, Inc.$291
- E.r. Squibb & Sons, L.L.C.$244
- LEO Pharma Inc.$240
- plus $2K from 15 others
What the payments were for
- Food & beverage$3,84996%
- Education$1654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $706 |
| Johnson & Johnson | 28 | $544 |
| Novartis | 15 | $328 |
| UCB, Inc. | 13 | $291 |
| E.r. Squibb & Sons, L.L.C. | 9 | $244 |
| LEO Pharma Inc. | 10 | $240 |
| Sanofi | 7 | $203 |
| Lilly USA, LLC | 7 | $182 |
| Sun Pharmaceutical Industries Inc. | 8 | $172 |
| Amgen | 6 | $171 |
| Regeneron Healthcare Solutions, Inc. | 7 | $165 |
| Incyte Corporation | 6 | $137 |
| Pfizer | 5 | $131 |
| Dermavant Sciences, Inc. | 5 | $110 |
| Boehringer Ingelheim | 4 | $99 |
| Galderma Laboratories, L.p. | 5 | $93 |
| Genentech USA, Inc. | 3 | $59 |
| Botanix SB Inc | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Organon | 1 | $35 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
How this compares
$4,014 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 45 | $2,492 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 30 | $2,144 |
| Metronidazole | 11 | $563 |
| Triamcinolone Acetonide | 48 | $445 |
| Clindamycin Phosphate | 13 | $422 |
| Mupirocin | 20 | $349 |
| Ketoconazole | 19 | $292 |
Paid to pharmacies, not to this prescriber.
Other family in Chestnut Hill
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
- Marissa CasilloFoxborough$31K
- Rochelle NazarianDanvers$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.